Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Descriptive Study of Baseline Features and Longitudinal Prognosis of Lymphoproliferative Manifestations in Primary Immunodeficiencies

NCT07526714 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT07526714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07526714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Descriptive Study of Baseline Features and Longitudinal Prognosis of Lymphoproliferative Manifestations in Primary Immunodeficiencies
Lead sponsor
Central Hospital, Nancy, France
Phase
Observational
Overall status
Not yet recruiting
Start date
April 1, 2026
Completion date
March 31, 2029
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

benign lymphoproliferative disorder, primary immune deficiencies